Table 3

Threshold effect analysis of LTL on prevalence of ED using the two-piecewise regression model

Leucocyte telomere length (T/S ratio)Adjusted OR (95% CI), p value
Fitting by the standard linear model1.01 (0.50 to 2.04), p=0.976
Fitting by the two-piecewise linear model
 Inflection point (1.037 (T/S ratio))
 Leucocyte telomere length <1.037 (T/S ratio)1.99 (0.39 to 10.20), p=0.385
 Leucocyte telomere length ≥1.037 (T/S ratio)0.17 (0.03 to 0.90), p=0.039
Log-likelihood ratio<0.001
  • Adjusted for age, race/ethnicity, education level, smoking status, PIR, vigorous activity, moderate activity, alcohol consumption status, hypertension, diabetes, CVD, CKD, hyperlipidaemia and ED medications.

  • CKD, chronic kidney disease; CVD, cardiovascular disease; ED, erectile dysfunction; LDL, leucocyte telomere length; PIR, poverty income ratio.